Müge Çevik
#87,742
Most Influential Person Now
Researcher
Müge Çevik's AcademicInfluence.com Rankings
Müge Çevikcomputer-science Degrees
Computer Science
#11491
World Rank
#12182
Historical Rank
Computational Linguistics
#2907
World Rank
#2940
Historical Rank
Machine Learning
#5267
World Rank
#5334
Historical Rank
Artificial Intelligence
#5679
World Rank
#5762
Historical Rank
Download Badge
Computer Science
Müge Çevik's Degrees
- Masters Computer Engineering Istanbul Technical University
- Bachelors Computer Engineering Istanbul Technical University
Why Is Müge Çevik Influential?
(Suggest an Edit or Addition)According to Wikipedia, Müge Çevik is a physician who is an infectious diseases researcher and science communicator at the University of St Andrews. Her research considers HIV, viral hepatitis, emerging infections and tropical infections in developing countries. During the COVID-19 pandemic, Çevik was an advisor to the Chief Medical Officer of Scotland and the World Health Organization, and is a member of New and Emerging Respiratory Virus Threats Advisory Group - an expert committee of the UK Department of Health advising Scientific Advisory Group for Emergencies.
Müge Çevik's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis (2020) (790)
- Virology, transmission, and pathogenesis of SARS-CoV-2 (2020) (474)
- COVID-19 pandemic—a focused review for clinicians (2020) (298)
- On the effect of age on the transmission of SARS-CoV-2 in households, schools and the community (2020) (170)
- Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol (2021) (165)
- Reopening Primary Schools during the Pandemic. (2020) (137)
- Prevalence of Asymptomatic SARS-CoV-2 Infection (2021) (135)
- On the Effect of Age on the Transmission of SARS-CoV-2 in Households, Schools, and the Community (2020) (132)
- Public health actions to control new SARS-CoV-2 variants (2021) (127)
- Towards an accurate and systematic characterisation of persistently asymptomatic infection with SARS-CoV-2 (2020) (126)
- Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial (2017) (122)
- Outcomes of COVID-19 related hospitalization among people with HIV in the ISARIC WHO Clinical Characterization Protocol (UK): a prospective observational study. (2020) (119)
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission Dynamics Should Inform Policy (2020) (112)
- Hospital-Acquired SARS-CoV-2 Infection: Lessons for Public Health. (2020) (102)
- COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants (2021) (95)
- The role of asymptomatic and pre-symptomatic infection in SARS-CoV-2 transmission—a living systematic review (2021) (81)
- Outcomes of Coronavirus Disease 2019 (COVID-19) Related Hospitalization Among People With Human Immunodeficiency Virus (HIV) in the ISARIC World Health Organization (WHO) Clinical Characterization Protocol (UK): A Prospective Observational Study (2020) (69)
- How to detect and reduce potential sources of biases in studies of SARS-CoV-2 and COVID-19 (2021) (67)
- SARS-CoV-2, SARS-CoV-1 and MERS-CoV Viral Load Dynamics, Duration of Viral Shedding and Infectiousness: A Living Systematic Review and Meta-Analysis (2020) (63)
- Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3 (2020) (60)
- Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 (2022) (54)
- What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocol (2020) (39)
- Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study (2022) (37)
- Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018 (2021) (32)
- Pneumocystis pneumonia, a COVID-19 mimic, reminds us of the importance of HIV testing in COVID-19. (2020) (30)
- Support for self-isolation is critical in covid-19 response (2021) (30)
- Covid-19 vaccination: evidence of waning immunity is overstated (2021) (29)
- SARS-CoV-2 viral load dynamics, duration of viral shedding and infectiousness: a living systematic review and meta-analysis (2020) (29)
- Global outbreak research: harmony not hegemony (2020) (28)
- Indirect Protection by Reducing Transmission: Ending the Pandemic With Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination (2021) (28)
- Networks of SARS-CoV-2 transmission (2021) (27)
- Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: Update of a living systematic review and meta-analysis (2022) (26)
- Global status of Toxoplasma gondii infection and associated risk factors in people living with HIV: A systematic review and meta-analysis. (2019) (24)
- Genetic determinants of idiopathic noncirrhotic portal hypertension in HIV-infected patients. (2013) (22)
- Availability, scope and quality of monkeypox clinical management guidelines globally: a systematic review (2022) (21)
- Outcomes of COVID-19 related hospitalisation among people with HIV in the ISARIC WHO Clinical Characterisation Protocol UK Protocol: prospective observational study (2020) (20)
- SARS-CoV-2 variants and considerations of inferring causality on disease severity (2021) (20)
- A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB (2021) (19)
- Transfusion-Transmitted Malaria: A Systematic Review and Meta-analysis (2019) (19)
- Emergent Resistance to Dolutegravir Among INSTI-Naïve Patients on First-line or Second-line Antiretroviral Therapy: A Review of Published Cases (2020) (19)
- Gender disparities in coronavirus disease 2019 clinical trial leadership (2021) (18)
- Acute hepatitis of unknown origin in children (2022) (18)
- An analysis of the Gezi Park social movement tweets (2017) (16)
- Competing Health Risks Associated with the COVID-19 Pandemic and Early Response: A Scoping Review (2021) (16)
- Covid-19 vaccines, immunity, and boosters (2021) (16)
- Organization and training at national level of antimicrobial stewardship and infection control activities in Europe: an ESCMID cross-sectional survey (2019) (14)
- How scientists and physicians use Twitter during a medical congress. (2019) (14)
- Defining the role of asymptomatic SARS-CoV-2 transmission: a living systematic review (2020) (13)
- Pulmonary Illness Related to E-Cigarette Use. (2019) (12)
- Investigation of a healthcare‐associated Candida tropicalis candidiasis cluster in a haematology unit and a systematic review of nosocomial outbreaks (2020) (11)
- A switch to Raltegravir improves antiretroviral associated hepatotoxicity in individuals co-infected with HIV and hepatitis C. (2014) (9)
- Current mentorship practices in the training of the next generation of clinical microbiology and infectious disease specialists: an international cross-sectional survey (2019) (9)
- Competing Health Risks Associated with the COVID-19 Pandemic and Response: A Scoping Review (2021) (8)
- How to detect and reduce potential sources of biases in epidemiologic studies of SARS-CoV-2 (2020) (7)
- Management of Orbital Complications of Acute Rhinosinusitis in Pediatric Patients: A 15-Year Single-Center Experience. (2019) (7)
- Safety and efficacy of fixed‐dose combination rilpivirine‐tenofovir‐emtricitabine (RPV/TDF/FTC) in treatment‐experienced patients infected with HIV‐1 (2012) (6)
- Non-typeable Haemophilus influenzae-associated early pregnancy loss: an emerging neonatal and maternal pathogen (2019) (6)
- Dolutegravir use in combination with rifampicin-based tuberculosis therapy: 3 years of real-world experience in a large UK teaching hospital (2018) (6)
- Should masks be worn outdoors? (2021) (5)
- Aims and challenges of building national trainee networks in clinical microbiology and infectious disease disciplines. (2021) (5)
- Fixed dose darunavir boosted with cobicistat combined with emtricitabine and tenofovir alafenamide fumarate (2018) (5)
- An evaluation of global Chikungunya clinical management guidelines: A systematic review (2022) (5)
- Association between women's authorship and women's editorship in infectious diseases journals: a cross-sectional study. (2022) (4)
- The Convergent Effect of International Collaboration between Young Leaders of Two Global Societies: Strengthening Microbiology Education and Training Practices Worldwide (2019) (3)
- Competing health risks associated with the COVID-19 pandemic and early response: A scoping review (2022) (3)
- An exceptional case report of disseminated cryptococcosis in a hitherto immunocompetent patient (2020) (2)
- International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK (2016) (2)
- A population framework for predicting the proportion of people infected by the far-field airborne transmission of SARS-CoV-2 indoors (2021) (2)
- Comment on: Doxycycline in UK guidelines for hospital-acquired pneumonia: where is the evidence base? (2019) (2)
- Raltegravir switch improves hepatitis C transaminitis in HIV-1 and hepatitis C (HCV) co-infected individuals (2012) (2)
- Insights into HIV-1 capsid inhibitors in preclinical and early clinical development as antiretroviral agents (2019) (2)
- Role and perception of clinical microbiology and infectious diseases trainees during the COVID-19 crisis (2022) (1)
- A Partially-Randomised Phase 3 Trial of Pretomanid, Moxifloxacin and Pyrazinamide in Combination for the Treatment of Drug-Susceptible and Drug-Resistant Pulmonary Tuberculosis (2020) (1)
- Risk factors associated with poor clinical outcome in pyogenic spinal infections: 5-years' intensive care experience. (2020) (1)
- Social media to engage, communicate and interact. (2019) (1)
- Corrigendum to: Transfusion-Transmitted Malaria: A Systematic Review and Meta-Analysis (2020) (1)
- An open letter to Oran and Topol, and the Annals of Internal Medicine (2020) (1)
- Mpox virus and transmission through sexual contact: Defining the research agenda (2023) (1)
- Challenges of interpreting CMV DNAemia and its potential association with chronic lung disease in children and adolescents with perinatally acquired HIV infection. (2019) (1)
- Safety and efficacy of rilpivirine-tenofovir-emtricitabine (Eviplera (R)) in hepatitis C-HIV coinfection (2013) (0)
- Reply to: COVID-19, children, and schools: overlooked and at risk (2020) (0)
- Does Wheels of Retailing Hold for Turkish Retailers (2010) (0)
- Estimating the global impact of coronavirus disease 2019 on people living with HIV (2022) (0)
- In-person schooling is essential even during periods of high transmission of COVID-19 (2023) (0)
- Doxycycline for the empiric treatment of low-severity hospital acquired pneumonia (2020) (0)
- Current mentorship practices in the training of the next generation of clinical microbiology and infectious disease specialists: an international cross-sectional survey (2019) (0)
- Insights into HIV-1 Capsid Inhibitors in early clinical development as antiretroviral agents (2019) (0)
- Expect the unexpected e Implications for next phase of COVID-19 response (2021) (0)
- Omicron variant: assessing the duration of viral shedding and its implications (2022) (0)
- A Subgroup of Patients With Hospital-acquired Pneumonia Do Not Require Broad-spectrum Gram-negative Antimicrobial Coverage (2020) (0)
- Gender disparities in international COVID-19 clinical trial leadership (2020) (0)
- COVID‐19, children and schools: overlooked and at risk (2021) (0)
- Experience of managing TB/HIV infection in a regional UK center over a 5 year period (2016) (0)
- Eleventh International Congress on Drug Therapy in HIV Infection (2012) (0)
- Expect the unexpected – Implications for next phase of COVID-19 response (2021) (0)
- Eleventh International Congress on Drug Therapy in HIV Infection (2012) (0)
- Tracking social protests with twitter: an analysis of the Gezi Park demonstrations (2015) (0)
- Standard of care for viral haemorrhagic fevers (VHFs): a systematic review of clinical management guidelines for high-priority VHFs. (2023) (0)
- Raltegravir switch improves hepatitis C transaminitis in HIV-1 and hepatitis C (HCV) co-infected individuals (2012) (0)
- ISARIC Covid-19 Follow Up study (2020) (0)
- NERVTAG paper Note on growth rate of SARS-CoV-2 B.1.1.7 (0)
- COVID-19 challenges and solutions: New variants of COVID-19: extent, impact and response (2021) (0)
This paper list is powered by the following services:
Other Resources About Müge Çevik
What Schools Are Affiliated With Müge Çevik?
Müge Çevik is affiliated with the following schools:
